[HTML][HTML] The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
[HTML][HTML] The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives
H Walgrave, L Zhou, B De Strooper… - Molecular …, 2021 - ncbi.nlm.nih.gov
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives
H Walgrave, L Zhou, B De Strooper… - Molecular …, 2021 - discovery.ucl.ac.uk
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives.
H Walgrave, L Zhou, B De Strooper… - Molecular …, 2021 - go.gale.com
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
[HTML][HTML] The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives
H Walgrave, L Zhou… - Molecular …, 2021 - molecularneurodegeneration …
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives.
H Walgrave, L Zhou, B De Strooper… - Molecular …, 2021 - europepmc.org
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives
H Walgrave, L Zhou, B De Strooper… - Molecular …, 2021 - pure.knaw.nl
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives.
H Walgrave, L Zhou, B De Strooper… - Molecular …, 2021 - search.ebscohost.com
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives
H Walgrave, L Zhou, B De Strooper… - Molecular …, 2021 - lirias.kuleuven.be
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives
H Walgrave, L Zhou… - Molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …
alternatives to classical monotarget therapies and microRNAs are of particular interest in …